DOCETAXEL ANHYDROUS for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where DOCETAXEL ANHYDROUS was used for Neoplasm malignant.
Most Reported Side Effects for DOCETAXEL ANHYDROUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Alopecia | 1,047 | 96.6% | 4 | 4 |
| Hair texture abnormal | 406 | 37.5% | 2 | 4 |
| Hair colour changes | 404 | 37.3% | 2 | 4 |
| Hair disorder | 393 | 36.3% | 2 | 4 |
| Madarosis | 368 | 34.0% | 2 | 5 |
| Anxiety | 107 | 9.9% | 0 | 0 |
| Emotional distress | 83 | 7.7% | 0 | 0 |
| Depression | 61 | 5.6% | 0 | 0 |
| Discomfort | 38 | 3.5% | 0 | 0 |
| Deformity | 34 | 3.1% | 0 | 0 |
| Pain | 33 | 3.0% | 0 | 0 |
| Impaired quality of life | 31 | 2.9% | 0 | 0 |
| Hair growth abnormal | 22 | 2.0% | 0 | 0 |
| Mental fatigue | 21 | 1.9% | 0 | 0 |
| Injury | 13 | 1.2% | 0 | 0 |
Other Indications for DOCETAXEL ANHYDROUS
Breast cancer female (134)
Product used for unknown indication (134)
Breast cancer (95)
Chemotherapy (86)
Breast cancer metastatic (18)
Triple negative breast cancer (14)
Invasive ductal breast carcinoma (12)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)